Article
Open Access
Molecular drug targets and therapies for Alzheimer’s disease
-
Dev Singh
,
Manish Gupta
Published/Copyright:
August 15, 2014
Published Online: 2014-8-15
Published in Print: 2014-9-1
© 2014 Versita Warsaw
Articles in the same Issue
- Transcranial magnetic stimulation modulates left premotor cortex activity in facial expression recognition as a function of anxiety level
- Deregulated microRNA expression in biospecimens from patients diagnosed with schizophrenia and bipolar disorder as a disease biomarker
- Pentose-phosphate pathway disruption in the pathogenesis of Parkinson’s disease
- Simple shelter-style environmental enrichment alters behavior in mice
- Neuroinflammation and Alzheimer’s disease: lessons learned from 5-lipoxygenase
- Molecular drug targets and therapies for Alzheimer’s disease
- Anosognosia for hemianesthesia: from the syndrome to tactile awareness
- Challenges in research on the neural basis of „chemobrain”
Keywords for this article
Alzheimer’s disease;
Amyloid β;
Tau protein;
Amyloid precursor protein;
β and Γ-secretases;
Glycogen synthase kinase-3;
Acyl-coenzyme A: cholesterol acyl-transferase (ACAT)
Creative Commons
BY-NC-ND 3.0
Articles in the same Issue
- Transcranial magnetic stimulation modulates left premotor cortex activity in facial expression recognition as a function of anxiety level
- Deregulated microRNA expression in biospecimens from patients diagnosed with schizophrenia and bipolar disorder as a disease biomarker
- Pentose-phosphate pathway disruption in the pathogenesis of Parkinson’s disease
- Simple shelter-style environmental enrichment alters behavior in mice
- Neuroinflammation and Alzheimer’s disease: lessons learned from 5-lipoxygenase
- Molecular drug targets and therapies for Alzheimer’s disease
- Anosognosia for hemianesthesia: from the syndrome to tactile awareness
- Challenges in research on the neural basis of „chemobrain”
